Prevalence of metabolic disturbances among women with polycystic ovary syndrome in different regions of Brazil

被引:12
|
作者
Maffazioli, Giovana D. N. [1 ]
Lopes, Caroline P. [1 ]
Heinrich-Oliveira, Vanessa [1 ]
Lobo, Rogerio A. [2 ]
Hayashida, Sylvia A. Y. [1 ]
Soares, Jose Maria, Jr. [1 ]
Maciel, Gustavo A. R. [1 ]
Baracat, Edmund C. [1 ]
机构
[1] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Disciplina Ginecol,Dept Obstet & Ginecolo, Sao Paulo, Brazil
[2] Columbia Univ, Dept Obstet & Gynecol, New York, NY USA
基金
巴西圣保罗研究基金会;
关键词
Diabetes; Dyslipidemia; Hyperinsulinemia; Metabolic syndrome; Metabolism; Polycystic ovary syndrome; INSULIN-RESISTANCE; DIFFERENT PHENOTYPES; CARDIOVASCULAR RISK; ROTTERDAM CRITERIA; GENOMIC ANCESTRY; SYNDROME PCOS; ASSOCIATION; GLUCOSE; OBESITY; HYPERANDROGENISM;
D O I
10.1002/ijgo.13374
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To describe the prevalence of metabolic disturbances in a large cohort of women with polycystic ovary syndrome (PCOS) in southeastern Brazil and to compare the findings with other cohorts of Brazilian women with PCOS. Methods A retrospective study analyzing clinical and laboratory data of 462 women with PCOS treated at an outpatient clinic in a tertiary hospital in southeastern Brazil. Prevalence of insulin resistance, glucose intolerance, type 2 diabetes, dyslipidemia, central obesity, hypertension, and metabolic syndrome was compared to that of other cohorts of age and body mass index-matched Brazilian women with PCOS. Results Women with PCOS had a median age of 25.0 (21.0-29.0) years and BMI of 28.7 (23.9-34.0) kg/m(2). Prevalence of insulin resistance, glucose intolerance, and type 2 diabetes varied from 39.6% to 55.0%, 7.2% to 28.1%, and 2.0% to 4.1%, respectively. Prevalence of central obesity, dyslipidemia due to decreased high-density lipoprotein cholesterol, hypertriglyceridemia, and metabolic syndrome ranged from 57.8% to 66.4%, 54.1% to 70.4%, 22.9% to 35.1%, and 27.4% to 38.3%, respectively, which did not differ among regions in Brazil. Conclusion Prevalence of metabolic disturbances was high among Brazilian women with PCOS. This study suggests that, from a public health perspective, authorities in Brazil should be aware of and encourage screening for metabolic dysfunction in women with PCOS in all regions of the country.
引用
收藏
页码:383 / 391
页数:9
相关论文
共 50 条
  • [41] Association of Insulin Resistance with Lipid Profile, Metabolic Syndrome, and Hormonal Aberrations in Overweight or Obese Women with Polycystic Ovary Syndrome
    Ebrahimi-Mamaghani, Mehranghiz
    Saghafi-Asl, Maryam
    Pirouzpanah, Saeed
    Aliasgharzadeh, Akbar
    Aliashrafi, Soudabeh
    Rezayi, Niloufar
    Mehrzad-Sadaghiani, Mahzad
    JOURNAL OF HEALTH POPULATION AND NUTRITION, 2015, 33 (01) : 157 - 167
  • [42] Association between Dietary Carbohydrate Intake and Polycystic Ovary Syndrome among Reproductive Age Women
    Binobead, Manal Abdulaziz
    Abualamah, Sara Mohammed
    Alshuniaber, Mohammad A.
    AlSedairy, Sahar Abdulaziz
    Alhussain, Maha H.
    Albadr, Nawal A.
    Arzoo, Shaista
    AMERICAN JOURNAL OF HEALTH BEHAVIOR, 2024, 48 (04): : 1144 - 1156
  • [43] Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as Markers of Insulin Resistance and Metabolic Associated Disturbances in Young Argentine Women with Polycystic Ovary Syndrome
    Abruzzese, Giselle A.
    Cerrrone, Gloria E.
    Gamez, Juan M.
    Graffigna, Mabel N.
    Belli, Susana
    Lioy, Gustavo
    Mormandi, Eduardo
    Otero, Patricia
    Levalle, Oscar A.
    Motta, Alicia B.
    HORMONE AND METABOLIC RESEARCH, 2017, 49 (01) : 23 - 29
  • [44] Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China
    Feng, Jin-ge
    Guo, Yan
    Ma, Li-ang
    Xing, Jin
    Sun, Rui-feng
    Zhu, Wei
    JOURNAL OF COSMETIC DERMATOLOGY, 2018, 17 (03) : 511 - 517
  • [45] Lipid Accumulation Product is Related to Metabolic Syndrome in Women with Polycystic Ovary Syndrome
    Xiang, S.
    Hua, F.
    Chen, L.
    Tang, Y.
    Jiang, X.
    Liu, Z.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2013, 121 (02) : 115 - 118
  • [46] The metabolic syndrome in young Korean women with polycystic ovary syndrome
    Park, Hwi Ra
    Choi, Youngju
    Lee, Hye-Jin
    Oh, Jee-Young
    Hong, Young Sun
    Sung, Yeon-Ah
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 77 : S243 - S246
  • [47] Sleep disturbances in a community-based sample of women with polycystic ovary syndrome
    Moran, L. J.
    March, W. A.
    Whitrow, M. J.
    Giles, L. C.
    Davies, M. J.
    Moore, V. M.
    HUMAN REPRODUCTION, 2015, 30 (02) : 466 - 472
  • [48] Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes
    Graff, Scheila Karen
    Mario, Fernanda Missio
    Alves, Bruna Cherubini
    Spritzer, Poli Mara
    FERTILITY AND STERILITY, 2013, 100 (04) : 1081 - 1088
  • [49] Different phenotypes of polycystic ovary syndrome in Turkish women: clinical and endocrine characteristics
    Ates, Seda
    Sevket, Osman
    Sudolmus, Sinem
    Dane, Banu
    Ozkal, Fulya
    Uysal, Omer
    Dansuk, Ramazan
    GYNECOLOGICAL ENDOCRINOLOGY, 2013, 29 (10) : 931 - 935
  • [50] Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome
    Rasool, Shayaq Ul Abeer
    Ashraf, Sairish
    Nabi, Mudasar
    Rashid, Fouzia
    Fazili, Khalid Majid
    Amin, Shajrul
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (03) : 2098 - 2105